Department of Nephrology and Hypertension, University Hospital Schleswig-Holstein Campus Kiel, Christian-Albrechts-University, Kiel, Germany.
Scientific Institute of the AOK (WIdO), Berlin, Germany.
Nephrol Dial Transplant. 2023 Oct 31;38(11):2528-2536. doi: 10.1093/ndt/gfad099.
Outcome data regarding clinically relevant endpoints after starting dialysis for end-stage renal disease (ESRD) are sparse, and early events after starting dialysis are particularly underestimated. The aim of this study was to describe patient-focused outcomes in ESRD patients starting from first dialysis.
The data basis for this retrospective observational study were anonymized healthcare data from Germany's largest statutory health insurer. We identified ESRD patients who initiated dialysis in 2017. Deaths, hospitalizations and occurrence of functional impairment within 4 years after starting dialysis were recorded starting from first treatment. Hazard ratios in dialysis patients compared with an age- and sex-matched reference population without dialysis were generated, stratified by age.
The dialysis cohort included 10 328 ESRD patients who started dialysis in 2017. First dialysis was performed in-hospital for 7324 patients (70.9%), and 865 of these died during the same hospitalization. One-year mortality for ESRD patients initiating dialysis was 33.8%. Functional impairment occurred in 27.1% of patients, while 82.8% of patients required hospitalization within 1 year. Hazard ratios of dialysis patients compared with the reference population for mortality, functional impairment and hospitalization at 1-year were 8.6, 4.3 and 6.2. Dialysis patients <50 years were disproportionately affected, with >40-fold increased risk of adverse events compared with their peers.
The emergence of morbidity and mortality after starting dialysis for ESRD is significant, especially in younger patients. Patients have a right to be informed about the prognosis associated with their condition.
关于终末期肾病(ESRD)患者开始透析后临床相关结局的数据很少,并且透析开始后早期事件尤其被低估。本研究旨在描述开始透析的 ESRD 患者的以患者为中心的结局。
本回顾性观察研究的数据基础是德国最大的法定健康保险公司的匿名医疗保健数据。我们确定了 2017 年开始透析的 ESRD 患者。从首次治疗开始,记录透析开始后 4 年内的死亡、住院和功能障碍发生情况。按年龄分层,与未透析的年龄和性别匹配的参考人群相比,在透析患者中生成了死亡率的风险比。
透析队列包括 10328 名 2017 年开始透析的 ESRD 患者。7324 名患者(70.9%)在医院进行首次透析,其中 865 名患者在住院期间死亡。开始透析的 ESRD 患者的 1 年死亡率为 33.8%。27.1%的患者出现功能障碍,82.8%的患者在 1 年内需要住院治疗。与参考人群相比,透析患者在 1 年内的死亡率、功能障碍和住院治疗的风险比分别为 8.6、4.3 和 6.2。年龄<50 岁的透析患者受影响不成比例,与同龄人相比,发生不良事件的风险增加了 40 多倍。
ESRD 患者开始透析后出现的发病率和死亡率显著,尤其是在年轻患者中。患者有权了解与自身病情相关的预后信息。